Patents by Inventor Dale Edgar

Dale Edgar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Olanzapine analogs and methods of use thereof
    Patent number: 7807828
    Abstract: The invention relates to novel compounds and methods of using them for modulating sleep.
    Type: Grant
    Filed: August 10, 2006
    Date of Patent: October 5, 2010
    Assignee: Hypnion, Inc.
    Inventors: Michael Solomon, Dale Edgar, David Hangauer, Kazumi Shiosaki, James White
  • Quetiapine analogs and methods of use thereof
    Patent number: 7563785
    Abstract: The invention relates to novel compounds and methods of using them for modulating sleep.
    Type: Grant
    Filed: September 21, 2005
    Date of Patent: July 21, 2009
    Assignee: Hypnion, Inc.
    Inventors: Dale Edgar, David Hangauer, Kazumi Shiosaki, Michael Solomon, James White
  • Benzisoxazole piperazine compounds and methods of use thereof
    Publication number: 20070004752
    Abstract: The invention includes benzisoxazole piperazine compositions and methods of using them for modulating sleep.
    Type: Application
    Filed: April 26, 2006
    Publication date: January 4, 2007
    Inventors: Daniel Coughlin, James White, Kazumi Shiosaki, David Hangauer, Michael Solomon, Dale Edgar
  • Quetiapine analogs and methods of use thereof
    Publication number: 20060094705
    Abstract: The invention relates to novel compounds and methods of using them for modulating sleep.
    Type: Application
    Filed: September 21, 2005
    Publication date: May 4, 2006
    Inventors: Dale Edgar, David Hangauer, Kazumi Shiosaki, Michael Solomon, James White
  • Loxapine analogs and methods of use thereof
    Publication number: 20060063928
    Abstract: The invention relates to novel compounds and methods of using them for modulating sleep.
    Type: Application
    Filed: September 21, 2005
    Publication date: March 23, 2006
    Inventors: Dale Edgar, David Hangauer, Kazumi Shiosaki, Michael Solomon, James White
  • Loxapine analogs and methods of use thereof
    Publication number: 20060063755
    Abstract: The invention relates to novel compounds and methods of using them for modulating sleep.
    Type: Application
    Filed: September 21, 2005
    Publication date: March 23, 2006
    Inventors: Dale Edgar, David Hangauer, Kazumi Shiosaki, Michael Solomon, James White
  • Methods of treating a sleep disorder
    Publication number: 20060063754
    Abstract: The invention relates to methods of modulating sleep.
    Type: Application
    Filed: September 21, 2005
    Publication date: March 23, 2006
    Inventors: Dale Edgar, David Hangauer, Kazumi Shiosaki, Michael Solomon, James White
  • Treatment of sleep disorders using sleep target modulators
    Publication number: 20060009465
    Abstract: The invention is directed to compositions used for treating sleep disorders. In addition, the invention provides convenient methods of treatment of a sleep disorder. Furthermore, the invention provides methods of treating sleep disorders using compositions that remain active for a discrete period of time to reduce side effects. More specifically, the invention is directed to the compositions and use of ester derivatized trazodone compounds for the treatment of sleep disorders.
    Type: Application
    Filed: January 21, 2003
    Publication date: January 12, 2006
    Inventors: Dale Edgar, David Hangauer, Harry Leighton
  • Doxepin analogs and methods of use thereof
    Publication number: 20050256165
    Abstract: The invention relates to novel doxepin analog compounds and methods of modulating sleep by administering such compounds, or a pharmaceutically effective salt thereof.
    Type: Application
    Filed: April 25, 2005
    Publication date: November 17, 2005
    Inventors: Dale Edgar, David Hangauer, James White, Michael Solomon
  • Methods of treating sleep disorders
    Publication number: 20050239838
    Abstract: The invention relates to novel antihistamines and methods of modulating sleep by administering a doxepin analog or a pharmaceutically effective salt thereof.
    Type: Application
    Filed: April 25, 2005
    Publication date: October 27, 2005
    Inventors: Dale Edgar, David Hangauer
  • Doxepin analogs and methods of use thereof
    Publication number: 20050171160
    Abstract: The invention relates to novel doxepin analog compounds and methods of modulating sleep by administering such compounds, or a pharmaceutically effective salt thereof.
    Type: Application
    Filed: December 10, 2004
    Publication date: August 4, 2005
    Inventors: Dale Edgar, David Hangauer, James White, Michael Solomon
  • Doxepin analogs and methods of use thereof
    Publication number: 20050143348
    Abstract: The invention relates to novel antihistamines and methods of modulating sleep by administering a doxepin analog or a pharmaceutically effective salt thereof.
    Type: Application
    Filed: April 23, 2004
    Publication date: June 30, 2005
    Inventors: Dale Edgar, David Hangauer, James White, Michael Solomon
  • Treatment of CNS disorders using CNS target modulators
    Publication number: 20050080265
    Abstract: The invention is directed to compositions and methods useful for treating Central Nervous System (CNS) disorders. Furthermore, the invention provides compositions and methods of treating sleep disorders. More specifically, the invention is directed to the compositions and use of derivatized, histamine antagonists for the treatment of sleep disorders.
    Type: Application
    Filed: April 23, 2004
    Publication date: April 14, 2005
    Inventors: Dale Edgar, David Hangauer, Harry Leighton, Emmanuel Mignot, James White, Michael Solomon, Kazumi Shiosaki
  • Treatment of cns disorders using cns target modulators
    Publication number: 20050009730
    Abstract: The invention is directed to compositions used for treating Central Nervous System (CNS) disorders. In addition, the invention provides convenient methods of treatment of a CNS disorder. Furthermore, the invention provides methods of treating sleep disorders using compositions that remain active for a discrete period of time to reduce side effects. More specifically, the invention is directed to the compositions and use of derivatized, e.g., ester or carboxylic acid derivatized, antihistamine antagonists for the treatment of sleep disorders.
    Type: Application
    Filed: October 16, 2002
    Publication date: January 13, 2005
    Inventors: Dale Edgar, David Hangauer, Harry Leighton, Emmanuel Mignot